Your browser doesn't support javascript.
loading
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
Palandri, Francesca; Breccia, Massimo; Tiribelli, Mario; Bonifacio, Massimiliano; Benevolo, Giulia; Iurlo, Alessandra; Elli, Elena M; Binotto, Gianni; Tieghi, Alessia; Polverelli, Nicola; Martino, Bruno; Abruzzese, Elisabetta; Bergamaschi, Micaela; Heidel, Florian H; Cavazzini, Francesco; Crugnola, Monica; Bosi, Costanza; Isidori, Alessandro; Auteri, Giuseppe; Forte, Dorian; Latagliata, Roberto; Griguolo, Davide; Cattaneo, Daniele; Trawinska, Malgorzata; Bartoletti, Daniela; Krampera, Mauro; Semenzato, Gianpietro; Lemoli, Roberto M; Cuneo, Antonio; Di Raimondo, Francesco; Vianelli, Nicola; Cavo, Michele; Palumbo, Giuseppe A.
Afiliación
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Breccia M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
  • Tiribelli M; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Benevolo G; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Elli EM; Hematology Division, San Gerardo Hospital, ASST, Monza, Italy.
  • Binotto G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Tieghi A; Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Polverelli N; Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Martino B; Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy.
  • Abruzzese E; Division of Hematology, Ospedale S. Eugenio, Rome, Italy.
  • Bergamaschi M; Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Genoa, Italy.
  • Heidel FH; Internal Medicine II, Hematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany.
  • Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Crugnola M; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Bosi C; Division of Hematology, AUSL di Piacenza, Piacenza, Italy.
  • Isidori A; Haematology and Haematopoietic Stem Cell Transplant Center, AORMN (Azienda Ospedaliera Ospedali Riuniti Marche Nord), Pesaro, Italy.
  • Auteri G; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Forte D; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Latagliata R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
  • Griguolo D; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Trawinska M; Division of Hematology, Ospedale S. Eugenio, Rome, Italy.
  • Bartoletti D; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Krampera M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Semenzato G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Lemoli RM; Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Genoa, Italy.
  • Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Di Raimondo F; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Cavo M; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.
Hematol Oncol ; 38(3): 372-380, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32271957
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Crisis Blástica / Quinasas Janus / Mielofibrosis Primaria Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Crisis Blástica / Quinasas Janus / Mielofibrosis Primaria Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia